Jump to content

Valerii Shapovalov: Difference between revisions

From Medico-Pharmaceutical Law Universe (by Lumen SI)
Use English explanations and translated titles while preserving source identification
Add complete multilingual reference and language navigation
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
<div class="wiki-language-nav" style="padding:0.75em; border:1px solid #b5c8cd; border-radius:0.5em; margin-bottom:1em;">[[Valerii Shapovalov|English]] · [[Valerii Shapovalov/uk|Українська]] · [[Valerii Shapovalov/es|Español]] · [[Valerii Shapovalov/fr|Français]] · [[Valerii Shapovalov/de|Deutsch]] · [[Valerii Shapovalov/pt|Português]]</div>
'''Valerii Shapovalov''' is a contributor to the publications documented in this wiki. Also appears as Valeriy Shapovalov; Ukrainian name (original script): Шаповалов Валерій Володимирович. He is distinct from [[Valentyn Shapovalov]].
'''Valerii Shapovalov''' is a contributor to the publications documented in this wiki. Also appears as Valeriy Shapovalov; Ukrainian name (original script): Шаповалов Валерій Володимирович. He is distinct from [[Valentyn Shapovalov]].


Line 25: Line 26:
Publication coauthorship, institutional office and contribution to an individual concept are different relationships. See [[Research network]] for dated, work-specific connections and [[People and attribution]] for editorial principles. Profile databases can contain duplicate records or name variants; the ORCID identifier is an identity key, not proof that every listed claim has been independently audited.
Publication coauthorship, institutional office and contribution to an individual concept are different relationships. See [[Research network]] for dated, work-specific connections and [[People and attribution]] for editorial principles. Profile databases can contain duplicate records or name variants; the ORCID identifier is an identity key, not proof that every listed claim has been independently audited.
[[Category:People]]
[[Category:People]]
== Public research records before 2021 ==
The selected public records include counterfeit-medical-product conventions and information systems (2013), rural pharmacy sustainability (2014), chronic-pain provision (2015) and FDA-related comparative regulation (2016). See [[ORCID bibliography before 2021]] for the individual public work links and [[Research before 2021]] for publisher-grounded descriptions. These are bibliographic topic descriptions, not a claim of sole authorship or full-text review of every work.
Source: [https://orcid.org/0000-0002-6696-6380 public ORCID profile] and the exact work records linked in the guide.

Latest revision as of 00:52, 12 November 2026

Valerii Shapovalov is a contributor to the publications documented in this wiki. Also appears as Valeriy Shapovalov; Ukrainian name (original script): Шаповалов Валерій Володимирович. He is distinct from Valentyn Shapovalov.

Identity and public profiles

Dated institutional context

The SRUMPL management page, dated 16 May 2026, identifies him as honorary president and associates him with the forensic and pharmaceutical sector. The September 2025 drug-policy paper lists Lviv Medical University as his affiliation; these records describe different contexts and dates.

SRUMPL management record and the specific publications below provide the source context.

Selected publication connections

  • With Andriy Gudzenko, Valentyn Shapovalov and Viktoriya Shapovalova: the 2021 forensic-pharmacy complaints study, DOI 10.31435/rsglobal_sr/30042021/7517.
  • With Ivan Voloshyn-Haponov, Andrii Diachenko and Natalia Matsko: a 2025 editorial on illicit psychoactive-substance trafficking, mental public health and rehabilitation, publisher record. An editorial's proposals are not equivalent to demonstrated clinical outcomes.
  • With Oleksandr Veits, Olena Lavoshnyk and Olga Gubaryeva: vaccine-circulation governance and pharmaceutical administration (26 July 2025), publisher record.

Shared conceptual publications

The publisher records list this author among the six coauthors of The Concept of Medico-Pharmaceutical Law: Principles, Advantages and Risks of Integration (12 December 2025) and Vision 2035 – Medico-Pharmaceutical Law for Human Security (6 March 2026). These bylines apply to those editions, not automatically to every later revision or conceptual article.

Reading the record

Publication coauthorship, institutional office and contribution to an individual concept are different relationships. See Research network for dated, work-specific connections and People and attribution for editorial principles. Profile databases can contain duplicate records or name variants; the ORCID identifier is an identity key, not proof that every listed claim has been independently audited.

Public research records before 2021

The selected public records include counterfeit-medical-product conventions and information systems (2013), rural pharmacy sustainability (2014), chronic-pain provision (2015) and FDA-related comparative regulation (2016). See ORCID bibliography before 2021 for the individual public work links and Research before 2021 for publisher-grounded descriptions. These are bibliographic topic descriptions, not a claim of sole authorship or full-text review of every work.

Source: public ORCID profile and the exact work records linked in the guide.